Format

Send to

Choose Destination
J Allergy Clin Immunol Pract. 2019 Jan;7(1):228-230. doi: 10.1016/j.jaip.2018.07.011.

Prevention and Diagnosis of Severe T-Cell-Mediated Adverse Drug Reactions: Are We There Yet?

Author information

1
Institute for Immunology & Infectious Diseases, Murdoch University, Murdoch, Australia.
2
Department of Infectious Diseases, Austin Health, Heidelberg, Australia.
3
Institute for Immunology & Infectious Diseases, Murdoch University, Murdoch, Australia; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn. Electronic address: elizabeth.j.phillips@vanderbilt.edu.
PMID:
30598178
PMCID:
PMC6440535
DOI:
10.1016/j.jaip.2018.07.011
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center